Major Depression and Psoriasis: A Psychodermatological Phenomenon

Publisher： Karger

E-ISSN： 1660-5535|29|4|220-230

ISSN： 1660-5527

Source： Skin Pharmacology and Physiology, Vol.29, Iss.4, 2016-08, pp. : 220-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Impact of Residual Symptoms in Major Depression

By Israel Joshua A.  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2426-2440

MDPI

Access to resources Recommend Favorite

Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression

By De Berardis Domenico   Fornaro Michele   Serroni Nicola   Campanella Daniela   Rapini Gabriella   Olivieri Luigi   Srinivasan Venkataramanujam   Iasevoli Felice   Tomasetti Carmine   De Bartolomeis Andrea   Valchera Alessandro   Perna Giampaolo   Mazza Monica   Di Nicola Marco   Martinotti Giovanni   Di Giannantonio Massimo  

International Journal of Molecular Sciences, Vol. 16, Iss. 1, 2015-01 ,pp. : 1111-1130

MDPI

Access to resources Recommend Favorite

Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression

By  

Pharmacology, Vol. 97, Iss. 3-4, 2016-0 ,pp. : 184-188

Karger

Access to resources Recommend Favorite

New Developments in the Treatment of Psoriasis

By  

Skin Pharmacology and Physiology, Vol. 14, Iss. 3, 2001-06 ,pp. : 129-135

Karger

Access to resources Recommend Favorite

The Topical Treatment of Psoriasis

By  

Skin Pharmacology and Physiology, Vol. 16, Iss. 2, 2003-03 ,pp. : 69-83

Karger

Access to resources Recommend Favorite